Summarized by Masters of Longevity from PR Newswire.
Field PULSE: a medical research article previewing 12-month clinical follow-up data on a novel focal pulsed field ablation approach for atrial arrhythmia treatment, highlighting procedural workflow and clinical implications.
Key Takeaways
- The Field PULSE first-in-human trial reported 94.2% per-vein pulmonary vein isolation durability at 12 months with the optimized waveform.
- Median elapsed PVI ablation time was 13 minutes with a fastest recorded time of 7.7 minutes using subsecond focal PFA.
- Eighty percent of patients were free from atrial arrhythmias at 12 months and 49% received additional non-PV atrial ablation.
